Outlook on the Flexible Manufacturing Systems in the Pharmaceutical Industry Global Market to 2026 - Featuring Cytiva, Germfree Laboratories and IPM Technologies Among Others

News provided by

Oct 27, 2021, 07:30 ET

DUBLIN, Oct. 27, 2021 /PRNewswire/ -- The "Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry" report has been added to ResearchAndMarkets.com's offering.

This report provides a detailed description of flexible manufacturing systems in the pharmaceutical industry and the latest technologies in the market.

The report includes market estimates for different types of flexible manufacturing systems and also includes recent technological developments and assessments of product performance in the market.

The global market for flexible manufacturing systems in the pharmaceutical industry should grow from $1.8 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.

Modular manufacturing market for flexible manufacturing systems in the pharmaceutical industry should grow from $858.4 million in 2021 to $1.1 billion by 2026 with a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.

Data-driven manufacturing market for flexible manufacturing systems in the pharmaceutical industry should grow from $501.0 million in 2021 to $665.6 million by 2026 with a compound annual growth rate (CAGR) of 5.8% for the period of 2021-2026.

Based on the approach type, the flexible manufacturing systems in pharmaceutical industry is segmented into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing.

Based on application, the market is segmented into manufacturing, aseptic filling and others (research and development, clinical research and academic research).

Based on industry, the market is segmented into pharmaceutical and biotechnology.

The report discusses the qualitative and quantitative factors influencing the market growth. The market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints as well as the competition and key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions.

The report also emphasizes the company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report additionally provides insights on the market share and upcoming regional demand.

Some of the major market players discussed in the report are Cytiva, Jacobs Engineering Inc., Exyte GmbH, G-CON Manufacturing, KeyPlants AB and Germfree Laboratories Inc. For market estimates, data have been provided for the year 2019 as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

22 data tables and 20 additional tables
An overview of the global market for flexible manufacturing systems in the pharmaceutical industry
Estimation of the market size and analyses of the global market trends, with data from 2019, 2020, estimates for 2021 with projection of CAGR through 2026
Market share analysis of flexible manufacturing systems based on approaches, industry type, application, and geography, and identification of new opportunities, challenges, and technological changes within the industry
Detailed description of flexible manufacturing system, its working, objectives, benefits, and limitations
Detailed analysis of the regulatory framework and policies, reimbursement scenarios and key product and technology developments
Identification of economic and demographic factors affecting the market growth and market insights about the future of the industry
Information on quicker approval processes of regulatory authorities for the new drugs, and initiatives by international organizations to improve flexible manufacturing systems
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
Company profiles of major players in the market, including Cytiva, Jacobs Engineering Inc., Exyte GmbH, G-CON Manufacturing, KeyPlants AB and Germfree Laboratories Inc.

Increased emphasis on lowering manufacturing costs and unpredictable demand for different products, demands more flexible and agile facilities is one of the key factors driving the market. The need for process optimization and improvements in the supply chain are driving investment in automation technologies across the pharmaceutical industry, and the current rise in demand for biopharmaceuticals due to COVID-19 has driven the need for strategic changes in bioprocessing.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Flexible Manufacturing Systems-Overview
How Does a Flexible Manufacturing System Work?
Objectives of FMS
Benefits of FMS
Limitations of FMS
Flexibility in Pharmaceutical Manufacturing
Flexibility-The Future of Pharma Manufacturing
The New Pharma Reality
Single-use Systems for Biopharmaceuticals
Continuous Manufacturing
Modular Manufacturing
Industry 4.0 in Pharma Manufacturing
Time to Act
Artificial Intelligence
Increasing Adoption of Industrial Internet of Things (IIoT)
Conclusions
Regulatory Aspects
Current Goods Manufacturing Practices (CGMPs) Overview
Importance of CGMPs
Existing Regulatory Guidelines on CM

Chapter 4 Impact of COVID-19 Pandemic

Impact of COVID-19
Need for Modular Manufacturing Approach
Speed to Market
Flexible Capacity
The Vaccine Facility of the Future
U.S. Biocontainment Manufacturer Provides Mobile Laboratory Facility for Work on COVID-19 Vaccine
130,000 Square-foot Drug Manufacturing Facility in Seattle Area Developed COVID-19 Therapeutics
New Collaboration Between Exyte and Univercells Technologies for Quick Deployment of Vaccine Production Plants to Combat the COVID-19 Pandemic

Chapter 5 Market Dynamics

Market Drivers
Increased Emphasis on Lowering Manufacturing Costs and Unpredictable Demand for Different Products
Regulatory Authorities Support New Manufacturing Trends by Offering Quicker Approval Processes for New Drugs
The Need for Process Optimization and Improvements in the Supply Chain Is Driving Investment in Automation Technologies Across the Pharmaceutical Industry
Current Rise in Demand for Biopharmaceuticals Due to COVID-19 Has Driven the Need for Strategic Changes in Bioprocessing
Market Restraints
Slow Rate of Adoption as the Industry Faces a Large Existing Capital Footprints, and Inconsistency in the Global Regulatory Framework
Uncertain Regulatory Policies
Market Opportunities
Initiatives by International Organizations to Improve Flexible Manufacturing Systems
Rising Opportunities with Industry 4.0 and Pharma 4.0
Competitive Landscape
Cytiva
Jacobs
Exyte GmbH

Chapter 6 Market Breakdown by Approach

Global Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach
Modular Manufacturing
Market Size and Forecast
Data-driven Manufacturing
Key Benefits of Data-driven Manufacturing in the Pharmaceutical Industry
Market Size and Forecast
Single-use Manufacturing
Market Size and Forecast
Continuous Manufacturing
Market Size and Forecast

Chapter 7 Market Breakdown by Application

Global Flexible Manufacturing Systems in the Pharmaceutical Industry, by Application
Manufacturing
Market Size and Forecast
Aseptic Filling
Market Size and Forecast
Others
Market Size and Forecast

Chapter 8 Market Breakdown by Industry

Global Flexible Manufacturing Systems in the Pharmaceutical Industry Market, by End-Use Industry
Pharmaceutical
Market Size and Forecast
Biotechnology
Market Size and Forecast

Chapter 9 Market Breakdown by Region

Chapter 10 Company Profiles

Biologics Modular, Llc
Cytiva
ESC
Exyte Gmbh
G-Con Manufacturing Inc.
Germfree Laboratories Inc.
Ipm Technologies
Jacobs Engineering Group Inc.
Keyplants Ab
Moduleco Ltd. (Moduleco Pharma)
Modwave Llc
Univercells Technologies
Zeton Inc.

Chapter 11 Appendix: List of Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/x51vif

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets